Evidence map›Paper›PMID 30514904›Full record

ArticleCell research2019

Ubiquitination of Rheb governs growth factor-induced mTORC1 activation.

Lu Deng, Lei Chen, Linlin Zhao, Yan Xu, Xiaoping Peng, Xinbo Wang, Lin Ding, Jiali Jin, Hongqi Teng, Yanming Wang and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Cell research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 132 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Frontiers in oncology · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. AKT and DUBs: a bidirectional relationship.Cellular & molecular biology letters · 2025
    Review
  15. Review
  16. Article
  17. Role of the USP family in autophagy regulation and cancer progression.Apoptosis : an international journal on programmed cell death · 2025
    Review
  18. Article
  19. Article
  20. Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Lu DengTongji Unviersity Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, School of Life Sciences and Technolog, Tongji University, 200092, Shanghai, China.
Lei ChenTongji Unviersity Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, School of Life Sciences and Technolog, Tongji University, 200092, Shanghai, China.
Linlin ZhaoTongji Unviersity Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, School of Life Sciences and Technolog, Tongji University, 200092, Shanghai, China.
Yan XuShanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 200241, Shanghai, China.
Xiaoping PengTongji Unviersity Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, School of Life Sciences and Technolog, Tongji University, 200092, Shanghai, China.
Xinbo WangTongji Unviersity Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, School of Life Sciences and Technolog, Tongji University, 200092, Shanghai, China.
Lin DingTongji Unviersity Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, School of Life Sciences and Technolog, Tongji University, 200092, Shanghai, China.
Jiali JinTongji Unviersity Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, School of Life Sciences and Technolog, Tongji University, 200092, Shanghai, China.
Hongqi TengTongji Unviersity Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, School of Life Sciences and Technolog, Tongji University, 200092, Shanghai, China.
Yanming WangTongji Unviersity Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, School of Life Sciences and Technolog, Tongji University, 200092, Shanghai, China.
Weijuan PanShanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 200241, Shanghai, China.
Fei YuTongji Unviersity Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, School of Life Sciences and Technolog, Tongji University, 200092, Shanghai, China.
Lujian LiaoShanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 200241, Shanghai, China.
Li LiInstitute of Aging Research, Hangzhou Normal University, 311121, Hangzhou, China.
Xin GeDepartment of Clinical Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 200072, Shanghai, China.
Ping WangTongji Unviersity Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, School of Life Sciences and Technolog, Tongji University, 200092, Shanghai, China. wangp@tongji.edu.cn.
Shanghai Tenth People's Hospital · CNTongji University · CNEast China Normal University · CNHangzhou Normal University · CNInstitute of Biophysics · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mechanistic target of rapamycin mTOR complex 1 (mTORC1) plays a key role in the integration of various environmental signals to regulate cell growth and metabolism. mTORC1 is recruited to the lysosome where it is activated by its interaction with GTP-bound Rheb GTPase. However, the regulatory mechanism of Rheb activity remains largely unknown. Here, we show that ubiquitination governs the nucleotide-bound status of Rheb. Lysosome-anchored E3 ligase RNF152 catalyzes Rheb ubiquitination and promotes its binding to the TSC complex. EGF enhances the deubiquitination of Rheb through AKT-dependent USP4 phosphorylation, leading to the release of Rheb from the TSC complex. Functionally, ubiquitination of Rheb is linked to mTORC1-mediated signaling and  consequently regulates tumor growth. Thus, we propose a mechanistic model whereby Rheb-mediated mTORC1 activation is dictated by a dynamic opposing act between Rheb ubiquitination and deubiquitination that are catalyzed by RNF152 and USP4 respectively.

Indexed as

UbiquitinationAnimalsColorectal NeoplasmsGene Knockout TechniquesHCT116 CellsHEK293 CellsHumansIntercellular Signaling Peptides and ProteinsLysosomesMaleMechanistic Target of Rapamycin Complex 1MiceMice, KnockoutMice, NudeRas Homolog Enriched in Brain ProteinSirolimusIntercellular Signaling Peptides and ProteinsMechanistic Target of Rapamycin Complex 1Ras Homolog Enriched in Brain ProteinRHEB protein, humanRNF152 protein, humanSirolimusUbiquitin-Protein LigasesUbiquitin-Specific ProteasesUSP4 protein, humanUsp4 protein, mouse

Identifiers

PMID30514904
PMCPMC6355928
OpenAlexW2903397393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.